PROCEPT BioRobotics

Congratulations to the dedicated doctors using Aquablation? Therapy to treat BPH patients! Discover the benefits of our advanced, minimally invasive #BPHtreatment: https://bit.ly/3AsgxYA #MedEd #urologist

PROSTATE RESEARCH UPDATE: WATER III Trial Results from EAU 2025 The results of the independent, investigator-initiated WATER III randomized, multi-center, international trial was presented at the European Association of Urology Congress. The trial compared Aquablation? therapy to laser enucleation, a highly effective treatment for large prostates. The key outcomes between Aquablation therapy and laser enucleation were: ? Similar symptom score (IPSS) reduction ? Significantly lower rates of ejaculatory dysfunction (14.8% vs 77.1%) ? Significantly lower stress incontinence (0% vs 9.1%) The trial, included prostates measuring 80–180 ml, was conducted by surgeons from Germany and the United Kingdom between 2020 and 2024. Check out the full release: https://bit.ly/3DGIcah #EAU25 #AquablationTherapy Safety Information: https://bit.ly/48PsIM6

WATER III Data is here! Come by the PROCEPT BioRobotics? booth E36 to learn more about the highly anticipated WATER III, investigator-led trial—comparing Aquablation? therapy vs. Transurethral laser enucleation for large prostates—that was unveiled at EAU 2025’s Game Changer session. This international multicenter study showed Aquablation therapy delivers: ? Similar symptom score reduction to laser enucleation ? Significantly lower rates of ejaculatory dysfunction (14.8% vs 77.1%) ? Significantly lower stress incontinence (0% vs 9.1%) #Aquablation #BPH #GameChanger #EAU25 For safety information, please visit: https://bit.ly/48PsIM6

Aquablation? therapy - the results speak for themselves. Dr. Mark Swierzewski, of Watson Clinic is improving the lives of men with BPH in Polk County, Florida. This before-and-after video showcases restored flow and remarkable outcome for BPH patients. #FlowFriday Not all patients will experience the same results. Safety information: https://bit.ly/48PsIM6

Expert Insights at #EAU25! Heading to #EAU25 in Madrid? Don’t miss the latest in Aquablation? Therapy! ?? Visit us at Booth E36 to hear expert-led presentations ?? March 21–24, 2025 Expert Sessions Include: ? Mr. Neil Barber & Mr. Mark Rochester – Day Case Aquablation Therapy & Outcome Data ? Dr. Dean Elterman & Mr. Philip Charlesworth – 10+ Years of Global Aquablation Therapy Data ? Dr. Tiago Rodrigues – Aquablation Therapy Outcome Data Don’t miss these key insights shaping the future of BPH treatment! Full program here: https://bit.ly/3E4Jiwm #AquablationTherapy #Urology #BPH For safety information, please visit: https://bit.ly/48PsIM6

Myth: BPH symptoms are just a normal part of aging. Fact: While common, BPH symptoms like frequent urination and weak stream shouldn’t be ignored. Dr. Garrett Pohlman, a urologist at Kearney Urology Center, shares his perspective on why men shouldn’t simply tolerate BPH symptoms and how they can take action. He discusses Aquablation? therapy, a robotic-assisted, heat-free waterjet treatment, as a solution to alleviate prostate obstruction and improve quality of life. Prostate health matters—don't wait to seek help. Safety Information: https://bit.ly/48PsIM6

Untreated BPH is more than a urinary issue—it can affect kidney health. During National Kidney Month, it's important to highlight the long-term risks of chronic urinary retention, including bladder dysfunction, infections, and potential kidney damage. As urologists, educating patients on early intervention is key to protecting long-term urinary function and overall health. #NationalKidneyMonth #AquablationTherapy #BPH Safety information: https://bit.ly/48PsIM6

94 million men around the world experience benign prostatic hyperplasia (BPH) and 99% of them say it impacts their quality of life.(1,2) With Aquablation? therapy, we’re helping men get their lives back from BPH. Read more: https://bit.ly/3UZfcxt Safety Information: https://bit.ly/48PsIM6 Reference: 1. Roehrborm CG, et al. Clin Interv Aging. 2008. 2. Data on file, PROCEPT BioRobotics.

With nearly 30 years in the medical device industry, Stephen McGill, VP and GM, International, brings a wealth of expertise to PROCEPT BioRobotics?. His leadership in global sales, marketing, and business development has driven innovation at companies like Angiodynamics, AMS, Boston Scientific, and Stryker. Stephen is dedicated to expanding access to Aquablation? therapy and advancing BPH treatment worldwide. Watch to learn more about his impact. #Leadership #PROCEPT

Happy International Women’s Day! Today, we celebrate the amazing women on our team whose strength, innovation, and passion propel our mission and make us who we are. Here's to the women who inspire us daily! #IWD2025 #AccelerateAction